Stock Taper
Latest 13F filing data - Q3 2024
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Taysha Gene Therapies, Inc. | TSHA | 2.15M | $4.32M |
Tenaya Therapeutics, Inc. | TNYA | 1.5M | $2.9M |
Rezolute, Inc. | RZLT | 1.47M | $7.15M |
Nuvation Bio Inc. | NUVB | 1.35M | $3.09M |
ProQR Therapeutics N.V. | PRQR | 887.7K | $1.62M |
Roivant Sciences Ltd. | ROIV | 800K | $9.23M |
Savara Inc. | SVRA | 725K | $3.07M |
Annexon, Inc. | ANNX | 650K | $3.85M |
Absci Corporation | ABSI | 550K | $2.1M |
Olema Pharmaceuticals, Inc. | OLMA | 535K | $6.39M |
Corvus Pharmaceuticals, Inc. | CRVS | 500K | $2.64M |
Syndax Pharmaceuticals, Inc. | SNDX | 450K | $8.66M |
Replimune Group, Inc. | REPL | 450K | $4.93M |
Phathom Pharmaceuticals, Inc. | PHAT | 375K | $6.78M |
Tarsus Pharmaceuticals, Inc. | TARS | 350K | $11.51M |
Amylyx Pharmaceuticals, Inc. | AMLX | 325K | $1.05M |
TG Therapeutics, Inc. | TGTX | 310K | $7.25M |
REGENXBIO Inc. | RGNX | 265K | $2.78M |
CG Oncology Inc. | CGON | 250K | $9.43M |
Immunovant, Inc. | IMVT | 215K | $6.13M |